Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 4, 2001, Pages

  Henry, David A ^a   Carless, Paul A ^b   Moxey, Annette J ^b   O'Connell, Dianne ^c   Ker, Katharine ^d   Fergusson, Dean A ^e  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c South Western Sydney Area Hlt Serv   (Australia)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85096240188     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003602     Document Type: Review

References (46)

1. Bezwada HP, Nazarian DG, Henry DH, Booth RE. Preoperative use of recombinant human erythropoietin before total joint arthroplasty. Journal of Bone and Joint Surgery. American volume 2003;85-A:1795-800.
2. Billote DB, Glisson SN, Green D, Wixson RL. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. Journal of Bone and Joint Surgery. American volume 2002;84-A:1299-304.
3. Bouchard D, Marcheix B, Al-Shamary S, Vanden Eynden F, Demers P, Robitaille D, et al. Preoperative autologous blood donation reduces the need for allogeneic blood products: a prospective randomized study. Canadian Journal of Surgery 2008;51(6):422-7.
4. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. New England Journal of Medicine 1993;328(19):1372-6.
5. Busch OR, Hop WC, Marquet RL, Jeekel J. The effect of blood transfusions on survival after surgery for colorectal cancer. European Journal of Cancer 1995;31A(7-8):1226-8.
6. Christopoulou M, Derartinian H, Hatzidimitriou G, Iatrou L. Autologous blood transfusion in oral and maxillofacial surgery patients with the use of erythropoietin. Journal of Craniomaxillofacial Surgery 2001;29:118-25.
7. Ekback G, Schott U, Axelsson K, Carberg M. Perioperative autotransfusion and functional coagulation analysis in total hip replacement. Acta Anaesthesiologica Scandinavica 1995;39:390-5. [MEDLINE: 1919270]
8. Elawad AA, Jonsson S, Laurell M, Fredin H. Predonation autologous blood in hip arthroplasty. Acta Orthopaedica Scandinavica 1991;62(3):218-22.
9. Elewad AA, Fredin HO, Laurell M, Jonsson S. Elderly patients' responses to preoperative autologous blood collection. Medical Journal of Australia 1991;155(3):147-50.
10. Hedstrom M, Flordal PA, Ahl T, Svensson J, Dalen N. Autologous blood transfusion in hip replacement. No effect on blood loss but less increase of plasminogen activator inhibitor in a randomized series of 80 patients. Acta Orthopaedica Scandinavica 1996;67(4):317-20.
11. Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. Journal of Clinical Oncology 1994;12(9):1859-67.
12. Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery [published erratum appears in Lancet 1994 Jan 1;343(8888):64]. Lancet 1993;342(8883):1328-33.
13. Heiss MM, Fasol-Merten K, Allgayer H, Strohlein MA, Tarabichi A, Wallner S, et al. Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery. Vox Sanguinis 1997;73(4):237-45.
14. Heiss MM, Fraunberger P, Delanoff C, Stets R, Allgayer H, Strohlein MA, et al. Modulation of immune response by blood transfusion: evidence for differential effect of allogeneic and autologous blood in colorectal cancer surgery. Shock 1997;8(6):402-8.
15. Hoynck van Papendrecht MA, Hop W, Langenhorst BL, Kothe FC, Marquet RL, Jeekel J. Feasibility of a predeposit autologous blood donation program in colorectal cancer patients: results from a randomized clinical study. Vox Sanguinis 1992;62(2):102-7.
16. Kajikawa M, Nonami T, Kurokawa T, Hashimoto S, Harada A, Nakao A, et al. Autologous blood transfusion for hepatectomy in patients with cirrhosis and hepatocellular carcinoma: use of recombinant human erythropoietin. Surgery 1994;115:727-34.
17. Kostopanagiotou G, Pandazi A, Matsota P, Arkadopoulos N, Dalamanga N, et al. Effect of packed red blood cells transfusion on plasma fibronectin during liver resection. Transfusion Medicine 2007;17:115-8.
18. Lorentz A, Osswald PM, Schilling M, Jani L. A comparison of autologous transfusion procedures in hip surgery. Anaesthesist 1991;40(4):205-13.
19. Avall A, Hyliner M, Bengtson J, Carlsson L, Bengtsson A. Postoperative inflammatory response after autologous and allogeneic blood transfusion. Anesthesiology 1997;87:511-6.
20. Goodnough LT, Monk TG, Despotis GJ, Merkel K. A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty. Vox Sanguinis 1999;77(1):11-6.
21. Goodnough LT, Despotis GJ, Merkel K, Monk TG. A randomized trial comparing acute normovolemic hemodilution and preoperative autologous blood donation in total hip arthroplasty. Transfusion. 2000;40(9):1054-7.
22. Kiyama H, Ohshima N, Imazeki T, Yamada T. Autologous blood donation with recombinant human erythropoietin in anemic patients. Annals of Thoracic Surgery. 1999;68(5):1652-6.
23. Rubens FD, Dupuis JY, Robblee J, Rock G, Bryson GL, Wells PS. Feasibility of blinding in a randomized controlled trial comparing preoperative autologous blood donation and acute normovolemic hemodilution in adult cardiac surgery. Transfusion 2000;40(9):1058-62.
24. Stowell CP, Chandler H, Jove M, Guilfoyle M, Wacholtz MC. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty. Orthopedics 1999;22:s105-12.
25. Gomez-Barrera M, Izuel-Rami M, Garcia-Erce JA, Recasens V, Mendaza M, Rabanaque MJ. Study about the use of Epoetin Alfa, with or without autologous blood donation, in patients undergoing hip or knee orthopedic major surgery - poster 50. Transfusion Alternatives in Transfusion Medicine 2006;8(Suppl. 1):79.
26. Naumenko SE, Pokrovskii MG, Belavin AS, Kim SF. Blood-saving effectiveness of preoperative reservation of autoblood for surgical treatment of ischemic heart disease. Vestnik Khirurgii Imeni i - i - Grekova 2003;162(2):59-64.
27. Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Seminars in Hematology 1997;34(3 Suppl 2):34-40.
28. Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesthesia & Analgesia 1998;86(1):9-15.
29. Carless P, Moxey AJ, O'Connell D, Henry D. Autologous transfusion techniques: a systematic review of their efficacy. Transfusion Medicine 2004;14:123-44.
30. Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, et al. A pilot randomized trial comparing symptomatic vs hemoglobin-level-driven red blood cell transfusion following hip fracture. Transfusion 1998;38(6):522-9.
31. Coyle D, Lee KM, Fergusson DA, Laupacis A. Economic analysis of erythropoietin use in orthopaedic surgery. Transfusion Medicine 1999;9(1):21-30.
32. Faught C, Wells P, Fergusson D, Laupacis A. Adverse effects of methods for minimizing perioperative allogeneic transfusion: a critical review of the literature. Transfusion Medicine Reviews 1998;12(3):206-25.
33. Fergusson D, van Walraven C, Coyle D, Laupacis A. Economic evaluations of technologies to minimize perioperative transfusion: a systematic review of published studies. International Study of Peri-operative Transfusion (ISPOT) investigators. Transfusion Medicine Reviews 1999;13(2):106-17.
34. Fergusson D, Blair A, Henry D, Hisashige A, Huet C, Koopman-van G, et al. Technologies to minimize blood transfusion in cardiac and orthopedic surgery. Results of a practice variation survey in nine countries. International Study of Peri-operative Transfusion (ISPOT) Investigators. International Journal of Technology Assessment in Health Care 1999;15(4):717-28.
35. Forgie MA, Wells PS, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Archives of Internal Medicin 1998;158(6):610-6.
36. Goldman M, Remy-Prince S, Trepanier A, Decary F. Autologous donation error rates in Canada. Transfusion 1997;37(5):523-7.
37. Hebert PC, Wells G, Marshall J, Martin C, Tweeddale M, Pagliarello G, et al. Transfusion requirements in critical care. A pilot study. Canadian Critical Care Trials Group [published erratum appears in JAMA 1995 Sep 27;274(12):944]. JAMA 1995;273(18):1439-4.
38. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. New England Journal of Medicine 1999;340(6):409-17.
39. Henry DA, Moxey AJ, Carless PA, O'Connell D, Mcclelland B, Henderson KM, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD001886.pub2]
40. Huet C, Salmi LR, Fergusson D, Koopman-van Gemert AW, Rubens F, Laupacis A. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesthesia & Analgesia 1999;89(4):861-9.
41. Kimball AM, Berkley S, Ngugi E, Gayle H. International aspects of the AIDS/HIV epidemic. Annual Review of Public Health 1995;16:253-82.
42. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Anesthesia & Analgesia 1997;85(6):1258-67.
43. Laupacis A, Fergusson D. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Transfusion Medicine 1998;8(4):309-17.
44. McFarland W, Mvere D, Shandera W, Reingold A. Epidemiology and prevention of transfusion-associated human immunodeficiency virus transmission in sub-Saharan Africa. Vox Sanguinis 1997;72(2):85-92.
45. McVay PA, Andrews A, Hoag MS, Polan D, Skettino S, Stehling LC, et al. Moderate and severe reactions during autologous blood donations are no more frequent than during homologous blood donations. Vox Sanguinis 1990;59(2):70-2.
46. Whyte GS, Savoia HF. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria. Medical Journal of Australia 1997;166(11):584-6.